Recent Finacing
Recent Raise
Omniose develops polysaccharide protein conjugate vaccines via a proprietary enzymatic in‑cell E. coli bioconjugation platform that attaches capsular and O‑antigen polysaccharides to carrier proteins for Klebsiella pneumoniae.
